Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051457079> ?p ?o ?g. }
- W2051457079 endingPage "2535" @default.
- W2051457079 startingPage "2529" @default.
- W2051457079 abstract "This study aimed to determine the correlations of 7 histopathologic prognostic indicators of follicular lymphoma (follicular lymphoma grade, CD10 expression, Bcl-2 expression, IGH/BCL2 fusion, diffuse area, fibrosis, and marginal zone differentiation) with progression-free survival, overall survival, and follicular lymphoma histologic grade in 255 follicular lymphoma patients who were treated with rituximab-containing therapy. The complete response, overall response, 6-year progression-free survival, and 6-year overall survival rates were 83%, 96%, 56%, and 97%, respectively. Patients with follicular lymphoma grades 3a and 3b showed 100% 6-year and 10-year overall survival, and progression-free survival did not significantly differ between patients with follicular lymphoma grade 3 and those with follicular lymphoma grades 1 and 2. The absence or presence of Bcl-2 expression and intensity of Bcl-2 expression were not significant prognostic indicators of progression-free survival and overall survival. Likewise, the presence of IGH/BCL2 fusion, diffuse area, fibrosis, and marginal zone differentiation were not significantly correlated with progression-free survival and overall survival. Follicular lymphoma grade 3 was correlated with nodal disease and negative or lower intensity of Bcl-2 expression, but not with age, stage, or IGH/BCL2 status. In the prerituximab era, grade 3 disease was reported to be associated with a poor prognosis; however, the opposite was true for patients treated with rituximab-containing therapy, regardless of their age or disease stage. Bcl-2 expression and marginal zone differentiation were not prognostic indicators in follicular lymphoma patients treated with rituximab-containing therapy." @default.
- W2051457079 created "2016-06-24" @default.
- W2051457079 creator A5001620097 @default.
- W2051457079 creator A5002395792 @default.
- W2051457079 creator A5006743557 @default.
- W2051457079 creator A5013490553 @default.
- W2051457079 creator A5022629094 @default.
- W2051457079 creator A5036000764 @default.
- W2051457079 creator A5037105339 @default.
- W2051457079 creator A5049768782 @default.
- W2051457079 creator A5052874191 @default.
- W2051457079 creator A5060602384 @default.
- W2051457079 creator A5063851467 @default.
- W2051457079 creator A5090320088 @default.
- W2051457079 date "2013-11-01" @default.
- W2051457079 modified "2023-10-18" @default.
- W2051457079 title "Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy" @default.
- W2051457079 cites W148982835 @default.
- W2051457079 cites W1965354897 @default.
- W2051457079 cites W1990977776 @default.
- W2051457079 cites W1992641659 @default.
- W2051457079 cites W2004693302 @default.
- W2051457079 cites W2014126551 @default.
- W2051457079 cites W2029903835 @default.
- W2051457079 cites W2048925793 @default.
- W2051457079 cites W205637700 @default.
- W2051457079 cites W2087169226 @default.
- W2051457079 cites W2093193204 @default.
- W2051457079 cites W2094708089 @default.
- W2051457079 cites W2119941885 @default.
- W2051457079 cites W2124299012 @default.
- W2051457079 cites W2129313223 @default.
- W2051457079 cites W2132598458 @default.
- W2051457079 cites W2140652862 @default.
- W2051457079 cites W2147301704 @default.
- W2051457079 cites W2152599167 @default.
- W2051457079 cites W2170716753 @default.
- W2051457079 cites W2172351876 @default.
- W2051457079 cites W2227797770 @default.
- W2051457079 cites W2300995403 @default.
- W2051457079 cites W2324589728 @default.
- W2051457079 cites W2608724752 @default.
- W2051457079 cites W4252168887 @default.
- W2051457079 cites W4293203547 @default.
- W2051457079 doi "https://doi.org/10.1016/j.humpath.2013.06.013" @default.
- W2051457079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23916290" @default.
- W2051457079 hasPublicationYear "2013" @default.
- W2051457079 type Work @default.
- W2051457079 sameAs 2051457079 @default.
- W2051457079 citedByCount "24" @default.
- W2051457079 countsByYear W20514570792014 @default.
- W2051457079 countsByYear W20514570792016 @default.
- W2051457079 countsByYear W20514570792017 @default.
- W2051457079 countsByYear W20514570792018 @default.
- W2051457079 countsByYear W20514570792019 @default.
- W2051457079 countsByYear W20514570792020 @default.
- W2051457079 countsByYear W20514570792021 @default.
- W2051457079 countsByYear W20514570792022 @default.
- W2051457079 countsByYear W20514570792023 @default.
- W2051457079 crossrefType "journal-article" @default.
- W2051457079 hasAuthorship W2051457079A5001620097 @default.
- W2051457079 hasAuthorship W2051457079A5002395792 @default.
- W2051457079 hasAuthorship W2051457079A5006743557 @default.
- W2051457079 hasAuthorship W2051457079A5013490553 @default.
- W2051457079 hasAuthorship W2051457079A5022629094 @default.
- W2051457079 hasAuthorship W2051457079A5036000764 @default.
- W2051457079 hasAuthorship W2051457079A5037105339 @default.
- W2051457079 hasAuthorship W2051457079A5049768782 @default.
- W2051457079 hasAuthorship W2051457079A5052874191 @default.
- W2051457079 hasAuthorship W2051457079A5060602384 @default.
- W2051457079 hasAuthorship W2051457079A5063851467 @default.
- W2051457079 hasAuthorship W2051457079A5090320088 @default.
- W2051457079 hasConcept C126322002 @default.
- W2051457079 hasConcept C142724271 @default.
- W2051457079 hasConcept C143998085 @default.
- W2051457079 hasConcept C146357865 @default.
- W2051457079 hasConcept C151730666 @default.
- W2051457079 hasConcept C159654299 @default.
- W2051457079 hasConcept C187785154 @default.
- W2051457079 hasConcept C203014093 @default.
- W2051457079 hasConcept C2776694085 @default.
- W2051457079 hasConcept C2777058707 @default.
- W2051457079 hasConcept C2778453870 @default.
- W2051457079 hasConcept C2779338263 @default.
- W2051457079 hasConcept C2779921676 @default.
- W2051457079 hasConcept C2780653079 @default.
- W2051457079 hasConcept C2780739268 @default.
- W2051457079 hasConcept C71924100 @default.
- W2051457079 hasConcept C86803240 @default.
- W2051457079 hasConcept C90924648 @default.
- W2051457079 hasConceptScore W2051457079C126322002 @default.
- W2051457079 hasConceptScore W2051457079C142724271 @default.
- W2051457079 hasConceptScore W2051457079C143998085 @default.
- W2051457079 hasConceptScore W2051457079C146357865 @default.
- W2051457079 hasConceptScore W2051457079C151730666 @default.
- W2051457079 hasConceptScore W2051457079C159654299 @default.
- W2051457079 hasConceptScore W2051457079C187785154 @default.
- W2051457079 hasConceptScore W2051457079C203014093 @default.